Cytek Biosciences (CTKB)
(Delayed Data from NSDQ)
$5.30 USD
-0.05 (-0.93%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $5.30 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.01 |
EPS Last Quarter | -0.08 |
Last EPS Surprise | -166.67% |
ABR | 1.67 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.09 |
Next Year | 0.02 |
EPS (TTM) | -0.05 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 52.36M | 62.30M | 206.55M | 241.44M |
# of Estimates | 6 | 6 | 6 | 3 |
High Estimate | 53.80M | 66.70M | 210.05M | 246.48M |
Low Estimate | 50.00M | 58.77M | 203.05M | 238.50M |
Year ago Sales | 48.00M | 58.23M | 193.01M | 206.55M |
Year over Year Growth Est. | 9.08% | 6.98% | 7.01% | 16.89% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.01 | 0.04 | -0.09 | 0.02 |
# of Estimates | 4 | 4 | 3 | 3 |
Most Recent Consensus | -0.03 | 0.01 | -0.11 | -0.02 |
High Estimate | 0.01 | 0.07 | -0.07 | 0.08 |
Low Estimate | -0.03 | 0.01 | -0.11 | -0.02 |
Year ago EPS | 0.01 | 0.07 | 0.10 | -0.09 |
Year over Year Growth Est. | -200.00% | -42.86% | -190.00% | 118.52% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 1 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 1 | 1 | 0 |
Down Last 30 Days | 0 | 1 | 1 | 0 |
Down Last 60 Days | 0 | 1 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.01 | 0.04 | -0.09 | 0.02 |
7 Days Ago | -0.01 | 0.04 | -0.07 | 0.01 |
30 Days Ago | -0.01 | 0.04 | -0.07 | 0.01 |
60 Days Ago | -0.01 | 0.04 | -0.07 | 0.01 |
90 Days Ago | -0.01 | 0.04 | -0.07 | 0.01 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.01 | 0.04 | -0.07 | 0.08 |
Zacks Consensus Estimate | -0.01 | 0.04 | -0.09 | 0.02 |
Earnings ESP | 0.00% | 14.29% | 22.22% | 379.99% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.08 | -0.05 | 0.07 | 0.01 | NA |
Estimate | -0.03 | -0.05 | 0.03 | 0.02 | NA |
Difference | -0.05 | 0.00 | 0.04 | -0.01 | -0.01 |
Surprise | -166.67% | 0.00% | 133.33% | -50.00% | -20.84% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more